Financial reports
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
10-K
2022 FY
Annual report
28 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
1 Apr 22
NT 10-K
Notice of late annual filing
1 Apr 22
Current reports
8-K
United Health Products Provides Update on FDA PMA Application and Amendment to White Lion Agreement
31 Jan 23
8-K
United Health Products Announces Equity Financing Agreement and Provides Corporate Update
7 Sep 22
8-K
United Health Products Provides Update on FDA Review
19 Jul 22
8-K
United Health Products Announces Settlement of SEC Investigation
23 Jun 22
8-K
Regulation FD Disclosure
10 Jun 22
8-K
Other Events
29 Apr 22
8-K
Departure of Directors or Certain Officers
24 Feb 22
8-K
Regulation FD Disclosure
10 Dec 21
8-K
United Health Products Provides Business Update
14 Oct 21
8-K
United Health Products Provides Corporate Update and Announces Equity Financing
28 Jun 21
Registration and prospectus
S-8
Registration of securities for employees
12 Jun 23
S-8
Registration of securities for employees
20 Oct 22
424B3
Prospectus supplement
23 Sep 22
S-3
Shelf registration
7 Sep 22
S-8
Registration of securities for employees
3 Jun 22
S-8
Registration of securities for employees
4 Jan 22
S-3/A
Shelf registration (amended)
28 Sep 21
S-3
Shelf registration
29 Jun 21
S-8
Registration of securities for employees
1 Nov 19
D
$750K in equity, sold $56.73K, 5 investors
28 Jul 16
Proxies
DEF 14A
Definitive proxy
8 Jul 15
PRE 14A
Preliminary proxy
22 Jun 15
PRE 14A
Preliminary proxy
23 Dec 14
DEFA14C
Additional information
7 Jul 10
DEF 14C
Information statement
7 Jul 10
PRE 14C
Preliminary information
9 Jun 10
DEF 14C
Information statement
5 Feb 10
DEFA14C
Additional information
6 Nov 09
DEF 14A
Definitive proxy
2 Nov 09
DEF 14C
Information statement
2 Nov 09
Other
EFFECT
Notice of effectiveness
20 Sep 22
CORRESP
Correspondence with SEC
15 Sep 22
UPLOAD
Letter from SEC
14 Sep 22
EFFECT
Notice of effectiveness
30 Sep 21
CORRESP
Correspondence with SEC
29 Sep 21
UPLOAD
Letter from SEC
6 Jan 21
CORRESP
Correspondence with SEC
3 Nov 20
UPLOAD
Letter from SEC
29 Sep 20
CORRESP
Correspondence with SEC
15 Dec 09
UPLOAD
Letter from SEC
4 Dec 09
Ownership
4
Brian David Thom
17 May 23
144
Notice of proposed sale of securities
10 May 23
4
Brian David Thom
21 Apr 23
5
Kristofer Heaton
3 Feb 23
4
Brian David Thom
17 Jan 23
5
Brian David Thom
17 Jan 23
4
Brian David Thom
20 Sep 22
4
Brian David Thom
8 Jun 22
4/A
Brian David Thom
10 May 22
4
Brian David Thom
6 May 22